Library

Zidovudine

Athanor · official

C10H13N5O4 · 267.24 g/mol

IUPAC name: 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione

Also called AZT, Retrovir, azidothymidine, HIV

Open in Athanor
The structure of Zidovudine
Drawn from its SMILES with RDKit
Health hazardDangerSuspected of causing genetic defects · May cause cancer · Suspected of causing cancer · Suspected of damaging fertility or the unborn child · Causes damage to organs through prolonged or repeated exposure

Names and identifiers

IUPAC name
1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Synonyms
AZT, Retrovir, azidothymidine
+ 38 more

HIV, Azidothymidine, 3'-Azido-3'-deoxythymidine, Thymidine, 3'-azido-3'-deoxy-, Zidovudinum, Compound S, Zidovudina, BW A509U, zidovudin, BWA509U, BW-A-509U, 3'-Deoxy-3'-azidothymidine, BW-A509U, DTXSID8020127, DRG-0004, 3'-azt, 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione, 3'-Azidothymidine, NSC 602670, 4B9XT59T7S, 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, CHEBI:10110, BW-A 509U, NSC-602670, DTXCID60127, AZT Antiviral, TRIZIVIR COMPONENT ZIDOVUDINE, AZT, Antiviral, 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)-5-methylpyrimidine-2,4-(1H,3H)-dione, AZT (Antiviral), Antiviral AZT, LAMIVUDINE/ZIDOVUDINE TEVA COMPONENT ZIDOVUDINE, 3'-Azido-2',3'-Dideoxythymidine, BWA-509U, 3' Azido 3' deoxythymidine, BWA 509U, 3' Azido 2',3' Dideoxythymidine, 1-((2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl)-5-methylpyrimidine-2,4-dione

Molecular formula
C10H13N5O4
Empirical formula
C10H13N5O4
Molecular weight
267.24 g/mol
Exact mass
267.09675
CAS number
30516-87-1
PubChem CID
35370
Canonical SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]
Isomeric SMILES
CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]
InChI
InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1
InChIKey
HBOMLICNUCNMMY-XLPZGREQSA-N
Molfile

Names, InChI and the identifiers from PubChem, retrieved 2026-10-14.

Physical properties

TemperaturePressureDensity
Appearance
White to beige, crystalline solid[2]
2 values

From Hazardous Substances Data Bank (HSDB), the most authoritative source here.

ValueAs writtenSource
–3'-azido-3'-deoxythymidine is a slightly off-white odorless powdery solid. (NTP, 1992)[1] CAMEO Chemicalscites National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.
–shownWhite to beige, crystalline solid[2] Hazardous Substances Data Bank (HSDB)cites McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 2003. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2003 (Plus Supplements)., p. 737
Odor
Odorless[2]
Melting point
106 to 112 °C (223 to 234 °F, NTP 1992)[1]
Solubility in water
71 mg/ml in alc @ 25 °C[2]
3 values

From Hazardous Substances Data Bank (HSDB), the most authoritative source here.

ValueAs writtenSource
–10 to 50 mg/mL at 63 °F (NTP, 1992)[1] CAMEO Chemicalscites National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.
–shown71 mg/ml in alc @ 25 °C[2] Hazardous Substances Data Bank (HSDB)cites McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 2003. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2003 (Plus Supplements)., p. 737
–In water, 20,000 mg/l @ 25 °C[2] Hazardous Substances Data Bank (HSDB)cites McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 2003. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2003 (Plus Supplements)., p. 737
log P
log Kow = 0.05[2]
Vapor pressure
5.2 × 10⁻²⁰ mmHg @ 25 °C (estimated)[2]

Each value as its source reports it, with the source's number after it (listed under References). Where several sources report a property, the row shows the value most of them agree on, the rule the app uses; open the values to see every one.

Calculated

Heavy atoms
19
Rings
2
Aromatic rings
1
Fraction sp³ carbons (Fsp3)
0.6
H-bond donors
2
H-bond acceptors
5 computed here · PubChem 6
Rotatable bonds
3
TPSA (Ų)
133.1 computed here · PubChem 93.2
Formal charge
0
XLogP3
0 PubChem
Complexity
484 PubChem
Stereocenters
3 definedCIP: C5: R · C7: S · C11: S
Double-bond geometry
None specified
Point group
C1 of one 3D conformer with its hydrogens, by Athanor’s engine (as in the app)

Elemental analysis

  • C44.94%
  • H4.90%
  • N26.21%
  • O23.95%

Isotope pattern

100%267.09713%268.0991.6%269.101270.104

Each peak is a nominal mass with its abundance-weighted exact mass, as a percentage of the tallest, from IUPAC natural isotope abundances.

Computed from the structure with RDKit 2026.09 when this page was built, beside PubChem's own computed values from its record; where the two differ, both are shown.

Predicted

log P
-0.2 Crippen (Wildman and Crippen 1999)
log S (water solubility)
-1.41 ESOL (Delaney 2004), log mol/L
Synthetic accessibility
3.85 SA score, 1 easy to 10 hard (Ertl and Schuffenhauer 2009)

Drug-likeness: Lipinski’s rule of five

  • Molecular weight ≤ 500: 267.25
  • log P ≤ 5 (Crippen): -0.2
  • H-bond donors ≤ 5: 2
  • H-bond acceptors ≤ 10: 5

Passes all four rules.

¹³C NMR shifts, predicted

Predictions, not measurements; each names its method. A measured log P, where a source reports one, is under Physical properties.

Safety

Danger

Most widely reported: 99 company reports to ECHA. Source [3].

  • Health hazard
  • H341Suspected of causing genetic defects (54.5% of reports)
  • H350May cause cancer (53.5% of reports)
  • H351Suspected of causing cancer (45.5% of reports)
  • H361Suspected of damaging fertility or the unborn child (54.5% of reports)
  • H372Causes damage to organs through prolonged or repeated exposure (52.5% of reports)

Precautionary statements: P203, P260, P264, P270, P280, P318, P319, P405, P501

First aid

  • Eyes: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. Immediately transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop. Skin: Immediately flood affected skin with water while removing and isolating all contaminated clothing.[1]

Storage

  • Commercially available zidovudine ... Should be stored @ 15-25 °C. Zidovudine may not be adversely affected by short-term exposure to heat and sunlight, but capsules of the drug may become discolored or brittle as a result of such exposure and should be protected from light, heat, and moisture.[2]
  • Precautions FOR "carcinogens": Storage site should be as close as practical to lab in which carcinogens are to be used, so that only small quantities required for ... Expt need to be carried. Carcinogens should be kept in only one section of cupboard, an explosion-proof refrigerator or freezer (depending on chemicophysical properties ...) that bears appropriate label. An inventory ... Should be kept, showing quantity of carcinogen & date it was acquired ... Facilities for dispensing ... Should be contiguous to storage area. (chemical Carcinogens)[2]

Safety data sheets on the supplier’s page: abcr GmbH, Sigma-Aldrich, LGC Standards.

Always read the supplier’s safety data sheet before working with it.

Spectra

Experimental spectra held by these sources; each link opens the source's own record.

Literature

Reading PubChem, OpenAlex and GSRS…

Bioactivity

Reading ChEMBL…

References

  1. [1]CAMEO Chemicals · Public domain (NOAA) · via PubChem · retrieved 2026-10-14
  2. [2]Hazardous Substances Data Bank (HSDB) · Public domain (US NLM) · via PubChem · retrieved 2026-10-14
  3. [3]European Chemicals Agency (ECHA) · ECHA legal notice: reuse with acknowledgement · via PubChem · retrieved 2026-10-14
  4. [4]Human Metabolome Database (HMDB) · Linked only · via PubChem · retrieved 2026-10-14
  5. [5]SpectraBase · Linked only · via PubChem · retrieved 2026-10-14
  6. [6]NIST Mass Spectrometry Data Center · Linked only · via PubChem · retrieved 2026-10-14
  7. [7]MassBank Europe · Linked only · via PubChem · retrieved 2026-10-14
  8. [8]MassBank of North America (MoNA) · CC BY 4.0 · via PubChem · retrieved 2026-10-14
  9. ·Calculated values: computed by Athanor with RDKit 2026.09 from the structure.
  10. ·Literature on PubChem

Data last updated 2026-10-14.